Welcome to TRIZ Biopharma Innovation, the pioneering company behind Dynamic Self-Adapting Medical Drugs. We have developed a groundbreaking discovery that introduces a new paradigm in precision medicine—personalized and adaptive treatments that evolve in response to each patient’s unique biology. Unlike conventional drugs constrained by genetic variances, our dynamic drugs act like a ‘bunch of skeleton keys,’ ensuring nearly 100% efficacy by adapting to diverse biological targets. This revolutionary methodology integrates over 40 years of innovation, leveraging TRIZ (Theory of Inventive Problem Solving, based on patterns of evolution) in medicine and pharmaceuticals, along with cutting-edge AI technologies, to open the door to a transformative era in medicine. Join us as we redefine the future of healthcare with our visionary approach.

Boris Farber
Ph.D, Dr. Sci. Academician
Chief Executive Officer
> View Biography

Artur Martynov
Ph.D., Sc.D., Professor
Executive Vice President for Science
View Biography

ILya Kleyn M.D.,
M.D., Medical Advisor
>> View Biography

Daniel L. Beckles, M.D., Ph.D., FACS, FACC, FCCP
Chief Science Officer
>> View Biography

Sonya Farber M.S.
Communication manager
>> View Biography

Avi Kamelhar MPA
Business Advisor
>> View Biography

the development of dynamic drugs based on TRIZ principles

Location of our working groups:

all over the world